Delivery Order SPE2DB20D3101-SPE2DB24FRKW3
- Not listed
- The federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Vial 10mL to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,545.06 and a completion date of July 11, 2025. The contract is a Firm Fixed Price Delivery Order, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and allows for open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of 10 milliliter vials of insulin aspart 100 unit/milliliter. The award, with a ceiling value of $1,738.30, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order and has a firm fixed price pricing type, with a period of performance extending to July 10, 2023. The contract was not set aside for any specific type of business. AmerisourceBergen holds a...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $2,271.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL vials. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
- This federal contract award is for the delivery of 10 ml vials of Insulin Aspart 100 Unit/ml. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $7,692.48 and is a firm fixed price delivery order. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to...
- This federal contract award, valued at $3,640.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/mL Vial 10mL, a type of insulin medication. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 7, 2025. This award is not designated as a set-aside contract. The contract is part of a larger...
- This federal contract award, valued at $2,603.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564943786 - Insulin Aspart 100 Unit/mL in 10mL vials, with a completion date of June 20, 2024. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is valued at $27,385.46 and provides Insulin Aspart 100 Unit/mL in 10mL vials to the U.S. government. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a Firm Fixed Price delivery order contract. The contract has an ultimate completion date of August 8, 2024. This contract supports the DLA Troop Support Medical program, which is responsible for providing essential medical...
- This federal contract award is for the delivery of insulin aspart 100 unit/ml vials, with a ceiling value of $1,316.60. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract type is a delivery order, with a firm fixed price pricing arrangement, and an ultimate completion date of December 31, 2024. This award is not associated with any set-aside designation, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,145.34 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL vials. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,443.60 firm fixed price delivery order is for the supply of Insulin Aspart 100 Unit/mL vials. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRKW3Delivery Order
This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Vials (10 mL) to the Defense Logistics Agency (DLA). The contract, valued at $2,250.10, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 22, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/21/24 |